Table 1
Summary of reported cases of renal malakoplakia in Korea

Study Age/sex Past history Pyuria Bacteria BUN/Cr (mg/dL) Hemoglobin (g/dL) WBC (/μL) Computed tomography image Treatment Outcome
Cho et al. 1989 [6] 59/F (–) (–) No bacteria identified 16/1.0 10.9 8,400 20×25 cm sized mass-like lesion Nephrectomy Survival
Hong et al. 1992 [7] 66/F RA (+) No bacteria identified 20/1.4 9 28,200 Cystic mass-like lesion Nephrectomy+antibiotics Survival
Jung et al. 1993 [8] 66/F HTN, DM, RA NM E.coli (pleural effusion) NM 9 28,200 Mass-like lesion Nephrectomy Survival
Jo et al. 1996 [3] 66/M Old CVA, CLD, chronic pancreatitis (+) No bacteria identified 43/3.0 11.1 21,500 Kidney enlargement, multiple hypodense lesions Ciprofloxacin and TMP/SMX Survival; Cr 2.1 mg/dL
Kim et al. 2001 [9] 31/M S/p KT, IgAN NM No culture result reported 20/1.3 NM NM Not done Mycophenolate add Survival; Cr 1.7~1.8 mg/dL
Jeong et al. 2001 [10] 72/M Chronic alcoholics (+) No bacteria identified 64/9.0 8.9 23,400 Kidney enlargement TMP/SMX, rifampin, and ciprofloxacin + bethanecol and ascorbic acid+steroid pulse Tx. Survival; Cr 4.4 mg/dL
Sung et al. 2003 [11] 70/M Degenerative OA, HTN (–) No bacteria identified WNL 9.6 12,900 Well-enhanced necrotic multiseptated renal mass extending to the adjacent liver segment VI Nephrectomy and segmental, hepatectomy + Ciprofloxacin Survival
Jung et al. 2011 [1] 65/F HTN, DM, recurrent cystitis, degenerative arthritis (+) Yeast 2.1/0.89 9.8 7,160 Mass-like lesion in the left renal area TMP/SMX Survival
Yoon et al. 2012 [2] 51/F Thymoma, MG (+) E.coli WNL 8.6 20,900 27.4×11.2cm sized mass-like lesion Nephrectomy and gastrojejunostomy + Ciprofloxacin Survival
Present case, 2014 72/F HTN, PD (+) E.coli >200/8.38 11.4 13,950 Multiple hypodense lesions Ciprofloxacin and ubacillin Survival; Cr 2.5 mg/dL
BUN, blood urea nitrogen; Cr, serum creatinine level; WBC, white blood cell count; RA, rheumatoid arthritis; HTN, hypertension; DM, diabetes mellitus; NM, not mentioned; E.coli, Escherichia coli; CVA, cerebrovascular accident; CLD, chronic liver disease; TMP/SMX, trimethoprim/sulfamethoxazole; CP, chronic pancreatitis; IgAN, IgA nephropathy; Tx, treatment; OA, osteoarthritis; WNL, within normal limits; MG, Myasthenia gravis; PD, Parkinson’s disease.